ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 050 医学部, 大学院医学系研究科
  2. 0502 紀要・刊行物
  3. 05021 信州医学雑誌
  4. Vol. 71 No. 4

抗PD-1抗体薬治療により長期の病勢コントロールが得られているMSI-H/dMMR 転移性上行結腸癌の1例

http://hdl.handle.net/10091/0002001663
http://hdl.handle.net/10091/0002001663
f049685f-d8b7-4a6c-9c24-ad0d11595215
名前 / ファイル ライセンス アクション
shinshuishi71-4_3.pdf shinshuishi71-4_3.pdf
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2023-08-10
タイトル
タイトル 抗PD-1抗体薬治療により長期の病勢コントロールが得られているMSI-H/dMMR 転移性上行結腸癌の1例
タイトル
タイトル Programmed Death 1 Blockade Therapy with Long-lasting Disease Control in a Metastatic Ascending Colon Carcinoma with High-level Microsatellite Instability/Mismatch Repair Deficiency : Literature Review of the Case Report
言語
言語 jpn
DOI
関連タイプ isIdenticalTo
関連識別子 https://doi.org/10.11441/shinshumedj.71.225
関連名称 10.11441/shinshumedj.71.225
キーワード
主題 metastatic ascending colon cancer, mucinous carcinoma, MSI-H, Pembrolizumab
転移性上行結腸癌, 粘液癌, MSI-H, Pembrolizumab
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ journal article
著者 中村, 学

× 中村, 学

ja 中村, 学

Search repository
中山, 淳

× 中山, 淳

ja 中山, 淳

Search repository
信州大学研究者総覧へのリンク
氏名 中山, 淳
研究者URL https://soar-rd.shinshu-u.ac.jp/profile/ja.HCApHFkh.html
出版者
出版者 信州医学会
引用
内容記述 信州医学雑誌 71(4) : 225-233, (2023)
書誌情報 信州医学雑誌

巻 71, 号 4, p. 225-233, 発行日 2023-08-10
抄録
内容記述 A 70-year-old woman was admitted to our hospital because of anemia with headache and nausea. As a result of anemia workup, she was diagnosed with ascending colon cancer with a para-aortic lymph node metastasis. Ileocecal resection and excision of an enlarged para-aortic lymph node were performed. Histopathological diagnosis of the resected specimen was poorly differentiated adenocarcinoma (solid type) with some mucinous carcinoma, and the metastatic lymph nodes showed differentiation into mucinous carcinoma. Immunohistologically, CD8+T cell infiltration was observed in the cancer tissue, but mucinous carcinoma in the metastatic lymph nodes showed sparse CD8+T cell infiltration. During chemotherapy for liver metastases after surgery, lymph node metastases appeared near the hepatic hilum. The histology of lymph node metastases was diagnosed as mucinous carcinoma based on CT findings, and pembrolizumab was administered due to microsatellite instability-high.Twenty-two months after the start of treatment with pembrolizumab, the metastatic lymph nodes were judged to be in partial response and have maintained the reduction. The disappearance of liver metastases was confirmed 25 months after the start of pembrolizumab treatment. In our case, the time to partial response in the metastatic lymph nodes was longer than the reported median time to objective response to pembrolizumab. It is possible that the differentiation into mucinous carcinoma at the metastatic site caused the suppression of the infiltration of CD8-positive T cells into cancer cell clusters. The difference in time to response between mucinous and non-mucinous carcinoma in patients treated with immune checkpoint inhibitor is a matter for further study.
資源タイプ(コンテンツの種類)
ISSN
収録物識別子タイプ PISSN
収録物識別子 0037-3826
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AN00120815
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
戻る
0
views
See details
Views

Versions

Ver.1 2023-08-10 05:35:23.084563
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3